lobbying_activities: 1129027
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1129027 | 9098fb5d-3d4d-418d-aef0-37ee3f3e15cd | Q2 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2011 | second_quarter | PHA | Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. H.R.1540/S. 981- the "National Defense Authorization Act of FY 2012"- provisions related to the TRICARE program. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 630000 | 0 | 0 | 2011-07-20T10:57:14.267000-04:00 |